{"parse":{"title":"Estrogen and neurodegenerative diseases","pageid":41120978,"revid":859417047,"text":{"*":"<div class=\"mw-parser-output\"><p><b><a href=\"/wiki/Neurodegeneration\" title=\"Neurodegeneration\">Neurodegenerative diseases</a></b> can disrupt the normal human <a href=\"/wiki/Homeostasis\" title=\"Homeostasis\">homeostasis</a> and result in abnormal <b>estrogen</b> levels.<sup id=\"cite_ref-Fratiglioni_1-0\" class=\"reference\"><a href=\"#cite_note-Fratiglioni-1\">&#91;1&#93;</a></sup> For example,  neurodegenerative diseases can cause different physiological effects in males and females.  In particular, estrogen studies have revealed complex interactions with neurodegenerative diseases. Estrogen was initially proposed to be a possible treatment for certain types of neurodegenerative diseases but a plethora of harmful side effects such as increased susceptibility to <a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">breast cancer</a> and <a href=\"/wiki/Coronary_heart_disease\" class=\"mw-redirect\" title=\"Coronary heart disease\">coronary heart disease</a> overshadowed any beneficial outcomes. On the other hand, <a href=\"/wiki/Estrogen_Replacement_Therapy\" class=\"mw-redirect\" title=\"Estrogen Replacement Therapy\">Estrogen Replacement Therapy</a> has shown some positive effects with <a href=\"/wiki/Postmenopausal\" class=\"mw-redirect\" title=\"Postmenopausal\">postmenopausal</a> women.  Estrogen and estrogen-like molecules form a large family of potentially beneficial alternatives that can have dramatic effects on human homeostasis and disease.  Subsequently, large-scale efforts were initiated to screen for useful estrogen family molecules.  Furthermore, scientists discovered new ways to synthesize estrogen-like compounds that can avoid many side effects.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Estrogen\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Estrogen</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Application\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Application</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Neurodegenerative_Diseases\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Neurodegenerative Diseases</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Efforts_Made_on_Therapy\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Efforts Made on Therapy</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Estrogen_and_neurodegenerative_diseases\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Estrogen and neurodegenerative diseases</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Estrogen_and_Alzheimer&#39;s_disease\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Estrogen and Alzheimer's disease</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Estrogen_and_Parkinson&#39;s_disease\"><span class=\"tocnumber\">3.2</span> <span class=\"toctext\">Estrogen and Parkinson's disease</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Estrogen_and_Huntington&#39;s_disease\"><span class=\"tocnumber\">3.3</span> <span class=\"toctext\">Estrogen and Huntington's disease</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Estrogen_and_Amyotrophic_lateral_sclerosis\"><span class=\"tocnumber\">3.4</span> <span class=\"toctext\">Estrogen and Amyotrophic lateral sclerosis</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#Estrogen_Replacement_Therapy\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Estrogen Replacement Therapy</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-11\"><a href=\"#Main_Pathways\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">Main Pathways</span></a></li>\n<li class=\"toclevel-2 tocsection-12\"><a href=\"#Application_2\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">Application</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-13\"><a href=\"#Nonsteroidal_estrogens_and_neurodegenerative_diseases\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Nonsteroidal estrogens and neurodegenerative diseases</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-14\"><a href=\"#Application_3\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">Application</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-15\"><a href=\"#References\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Estrogen\">Estrogen</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=1\" title=\"Edit section: Estrogen\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:17-alpha-_vs_17-beta-estradiol.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/82/17-alpha-_vs_17-beta-estradiol.svg/220px-17-alpha-_vs_17-beta-estradiol.svg.png\" width=\"220\" height=\"172\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/82/17-alpha-_vs_17-beta-estradiol.svg/330px-17-alpha-_vs_17-beta-estradiol.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/82/17-alpha-_vs_17-beta-estradiol.svg/440px-17-alpha-_vs_17-beta-estradiol.svg.png 2x\" data-file-width=\"285\" data-file-height=\"223\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:17-alpha-_vs_17-beta-estradiol.svg\" class=\"internal\" title=\"Enlarge\"></a></div>17-alpha- vs 17-beta-estradiol</div></div></div>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Estrogen\" title=\"Estrogen\">Estrogen</a></div>\n<p>Estrogen is a lipid <a href=\"/wiki/Hormone\" title=\"Hormone\">hormone</a> in humans can regulate many physiological processes.<sup id=\"cite_ref-Leung_2-0\" class=\"reference\"><a href=\"#cite_note-Leung-2\">&#91;2&#93;</a></sup> It is largely related to <a href=\"/wiki/Menstrual\" class=\"mw-redirect\" title=\"Menstrual\">menstrual</a> and <a href=\"/wiki/Estrous\" class=\"mw-redirect\" title=\"Estrous\">estrous</a> and its biological function is mediated by binding to two receptors: <b>Estrogen Receptor alpha</b> (ER\u03b1) and <b>Estrogen Receptor beta</b> (ER\u03b2). These two receptors are tissue specific and have different influences on their downstream genes.<sup id=\"cite_ref-Pettersson_3-0\" class=\"reference\"><a href=\"#cite_note-Pettersson-3\">&#91;3&#93;</a></sup> A decrease in estrogen levels can lead to <a href=\"/wiki/Osteoporosis\" title=\"Osteoporosis\">osteoporosis</a>, <a href=\"/wiki/Cognitive_disorders\" class=\"mw-redirect\" title=\"Cognitive disorders\">cognitive disorders</a>, and can affect many important genes related to normal physiological function.\n</p><p>Estrogen can be divided into four classes: 1) Animal Estrogens that includes <a href=\"/wiki/Estrone\" title=\"Estrone\">estrone</a> (E1), <a href=\"/wiki/Estradiol\" title=\"Estradiol\">estradiol</a> (E2), and <a href=\"/wiki/Estriol\" title=\"Estriol\">estriol</a> (E3); 2) Plant Estrogens (<a href=\"/wiki/Phytoestrogens\" class=\"mw-redirect\" title=\"Phytoestrogens\">Phytoestrogens</a>); 3) Fungi Estrogens (<a href=\"/wiki/Mycoestrogens\" class=\"mw-redirect\" title=\"Mycoestrogens\">Mycoestrogens</a>) and 4) Synthetic Estrogens (<a href=\"/wiki/Xenoestrogens\" class=\"mw-redirect\" title=\"Xenoestrogens\">xenoestrogens</a>). Xenoestrogens contain a large number of compounds that are synthesized or naturally exist. These estrogens imitate estrogen structure and can be designed to satisfy the need of new drugs. They may have a significant impact on neurodegenerative disease treatment due to their ease of synthesis and targeted specificity.\n</p>\n<h3><span class=\"mw-headline\" id=\"Application\">Application</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=2\" title=\"Edit section: Application\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The application of estrogen on medicine can be divided into a number of aspects. The best known ones are <a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">breast cancer</a> and <a href=\"/wiki/Coronary_heart_disease\" class=\"mw-redirect\" title=\"Coronary heart disease\">coronary heart disease</a>. Estrogen also plays very important role in animal metabolism balance. These unexpected diseases hindered estrogen to get involved in neurodegenerative disease therapy. So, when applying estrogen-like drugs to relieve neurodegenerative diseases, the concentration should be restrictly controlled to avoid these side effects.\n</p>\n<h2><span class=\"mw-headline\" id=\"Neurodegenerative_Diseases\">Neurodegenerative Diseases</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=3\" title=\"Edit section: Neurodegenerative Diseases\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tleft\"><div class=\"thumbinner\" style=\"width:142px;\"><a href=\"/wiki/File:Parasagittal_MRI_of_human_head_in_patient_with_benign_familial_macrocephaly_prior_to_brain_injury_(ANIMATED).gif\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/56/Parasagittal_MRI_of_human_head_in_patient_with_benign_familial_macrocephaly_prior_to_brain_injury_%28ANIMATED%29.gif/140px-Parasagittal_MRI_of_human_head_in_patient_with_benign_familial_macrocephaly_prior_to_brain_injury_%28ANIMATED%29.gif\" width=\"140\" height=\"140\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/56/Parasagittal_MRI_of_human_head_in_patient_with_benign_familial_macrocephaly_prior_to_brain_injury_%28ANIMATED%29.gif/210px-Parasagittal_MRI_of_human_head_in_patient_with_benign_familial_macrocephaly_prior_to_brain_injury_%28ANIMATED%29.gif 1.5x, //upload.wikimedia.org/wikipedia/commons/5/56/Parasagittal_MRI_of_human_head_in_patient_with_benign_familial_macrocephaly_prior_to_brain_injury_%28ANIMATED%29.gif 2x\" data-file-width=\"256\" data-file-height=\"256\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Parasagittal_MRI_of_human_head_in_patient_with_benign_familial_macrocephaly_prior_to_brain_injury_(ANIMATED).gif\" class=\"internal\" title=\"Enlarge\"></a></div>Parasagittal MRI of human head in patient with benign familial macrocephaly prior to brain injury (ANIMATED)</div></div></div>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Neurodegeneration\" title=\"Neurodegeneration\">Neurodegeneration</a></div>\n<p>Neurodegenerative diseases are diseases caused along the process of <a href=\"/wiki/Neurodegeneration\" title=\"Neurodegeneration\">neurodegeneration</a>. Neurodegeneration includes structural and functional loss of neurons or even the death of the neurons. The causes of such diseases can be various but can be concluded into four aspects: <a href=\"/wiki/Mutation\" title=\"Mutation\">genetic mutation</a>, <a href=\"/wiki/Protein_misfolding\" class=\"mw-redirect\" title=\"Protein misfolding\">protein misfolding</a>, intracellular mechanisms and <a href=\"/wiki/Programmed_cell_death\" title=\"Programmed cell death\">programmed cell death</a>.\nMain classes of neurodegeneritive diseases are <a href=\"/wiki/Alzheimer%27s_disease\" title=\"Alzheimer&#39;s disease\">Alzheimer's disease</a>, <a href=\"/wiki/Parkinson%27s_disease\" title=\"Parkinson&#39;s disease\">Parkinson's disease</a>, <a href=\"/wiki/Huntington%27s_disease\" title=\"Huntington&#39;s disease\">Huntington's disease</a> and <a href=\"/wiki/Amyotrophic_lateral_sclerosis\" title=\"Amyotrophic lateral sclerosis\">Amyotrophic lateral sclerosis</a>.\n</p>\n<h3><span class=\"mw-headline\" id=\"Efforts_Made_on_Therapy\">Efforts Made on Therapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=4\" title=\"Edit section: Efforts Made on Therapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Different neurodegenerative diseases have different causes and are not well studied until now. There is no clear cure for such diseases but some efforts have been made to research deeper into them.\nThe 10th <a href=\"/w/index.php?title=Global_College_of_Neuroproetction_and_Neuroregeneration_Annual_Conference&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Global College of Neuroproetction and Neuroregeneration Annual Conference (page does not exist)\">Global College of Neuroproetction and Neuroregeneration Annual Conference</a> together with the International Association of Neurorestoratology VI was held to discuss on <a href=\"/w/index.php?title=Neurorestoration&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Neurorestoration (page does not exist)\">neurorestoration</a>, <a href=\"/wiki/Neuroprotection\" title=\"Neuroprotection\">neuroprotection</a> and <a href=\"/wiki/Neuroregeneration\" title=\"Neuroregeneration\">neuroregeneration</a> in various clinical neurodegenerative diseases like Alzheimer's, Parkinson's, Huntington's disease, <a href=\"/wiki/Stroke\" title=\"Stroke\">stroke</a> and brain or spinal cord injuries.<sup id=\"cite_ref-Sharma_4-0\" class=\"reference\"><a href=\"#cite_note-Sharma-4\">&#91;4&#93;</a></sup> The main aim was to enhance health care by the use of stem cells, <a href=\"/w/index.php?title=Nanodrug&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Nanodrug (page does not exist)\">nanodrug</a> delivery of drugs and stem cells, use of multimodal drugs as well as a combination of different approaches. They concluded that the future of neuroprotection could be achieved by the use of stem cells and nanodrug delivery in chronic neurological disorders.<sup id=\"cite_ref-Sharma_4-1\" class=\"reference\"><a href=\"#cite_note-Sharma-4\">&#91;4&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Estrogen_and_neurodegenerative_diseases\">Estrogen and neurodegenerative diseases</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=5\" title=\"Edit section: Estrogen and neurodegenerative diseases\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Although estrogen is best known for its effects on the maturation and differentiation of the primary and secondary sex organs, increasing evidence suggests that its influence extends beyond this system, and its activity in the <a href=\"/wiki/Central_nervous_system\" title=\"Central nervous system\">CNS</a> may initiate, or influence our susceptibility to neurodegenerative decline. Estrogen has been proposed to act as a <a href=\"/wiki/Neuroprotectant\" class=\"mw-redirect\" title=\"Neuroprotectant\">neuroprotectant</a> at several levels, and it is probable that deprivation of estrogen as a result of <a href=\"/wiki/Menopause\" title=\"Menopause\">menopause</a> exposes the aging or diseased brain to several insults. In addition, estrogen deprivation is likely to initiate or enhance degenerative changes caused by <a href=\"/wiki/Oxidative_stress\" title=\"Oxidative stress\">oxidative stress</a>, and to reduce the brain's ability to maintain synaptic connectivity and <a href=\"/wiki/Cholinergic\" title=\"Cholinergic\">cholinergic</a> integrity leading to the <a href=\"/wiki/Cognitive\" class=\"mw-redirect\" title=\"Cognitive\">cognitive</a> decline seen in aged and disease-afflicted individuals.<sup id=\"cite_ref-Gandy_5-0\" class=\"reference\"><a href=\"#cite_note-Gandy-5\">&#91;5&#93;</a></sup>\nThere is sufficient evidence that estradiol is a powerful <a href=\"/wiki/Neuroprotectant\" class=\"mw-redirect\" title=\"Neuroprotectant\">neuroprotectant</a> which might have use against AD, stroke and Parkinson's disease both in women and men.<sup id=\"cite_ref-Gandy_5-1\" class=\"reference\"><a href=\"#cite_note-Gandy-5\">&#91;5&#93;</a></sup>\n</p>\n<h3><span id=\"Estrogen_and_Alzheimer.27s_disease\"></span><span class=\"mw-headline\" id=\"Estrogen_and_Alzheimer's_disease\">Estrogen and Alzheimer's disease</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=6\" title=\"Edit section: Estrogen and Alzheimer&#039;s disease\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:APP_cleavage_produce_toxic_Abeta.png\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a8/APP_cleavage_produce_toxic_Abeta.png/220px-APP_cleavage_produce_toxic_Abeta.png\" width=\"220\" height=\"155\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a8/APP_cleavage_produce_toxic_Abeta.png/330px-APP_cleavage_produce_toxic_Abeta.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a8/APP_cleavage_produce_toxic_Abeta.png/440px-APP_cleavage_produce_toxic_Abeta.png 2x\" data-file-width=\"1184\" data-file-height=\"832\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:APP_cleavage_produce_toxic_Abeta.png\" class=\"internal\" title=\"Enlarge\"></a></div>This figure shows how APP cleavage produces toxic Abeta in Alzheimer's disease.</div></div></div>\n<p><a href=\"/wiki/Amyloid_plaques\" class=\"mw-redirect\" title=\"Amyloid plaques\">Amyloid plaques</a> formed by amyloid-\u03b2 (A\u03b2) deposition and <a href=\"/wiki/Neurofibrillary_tangles\" class=\"mw-redirect\" title=\"Neurofibrillary tangles\">neurofibrillary tangles</a> formed by tau protein phosphorylation are dominant physiological features of Alzheimer's disease. <a href=\"/wiki/Amyloid_precursor_protein\" title=\"Amyloid precursor protein\">Amyloid precursor protein</a> (APP) proteolysis is fundamental for production of A\u03b2 peptides implicated in AD pathology.<sup id=\"cite_ref-Zhang,_She-Qing_6-0\" class=\"reference\"><a href=\"#cite_note-Zhang,_She-Qing-6\">&#91;6&#93;</a></sup> By using a cell line that contains high levels of estrogen receptors, scientists found that treatment with physiological concentrations of 17 beta-estradiol is associated with accumulation in the conditioned medium of an amino-terminal cleavage product of APP (soluble APP or protease nexin-2), indicative of non-amyloidogenic processing.<sup id=\"cite_ref-JAFFE_7-0\" class=\"reference\"><a href=\"#cite_note-JAFFE-7\">&#91;7&#93;</a></sup>\n</p>\n<h3><span id=\"Estrogen_and_Parkinson.27s_disease\"></span><span class=\"mw-headline\" id=\"Estrogen_and_Parkinson's_disease\">Estrogen and Parkinson's disease</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=7\" title=\"Edit section: Estrogen and Parkinson&#039;s disease\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Estrogen deprivation leads to the death of <a href=\"/wiki/Dopamine\" title=\"Dopamine\">dopamine</a> cells in the brain that could have implications for post-menopausal women, but the majority of clinical reports support an antidopaminergic effect of estrogens on Parkinsonian symptoms.<sup id=\"cite_ref-Session_8-0\" class=\"reference\"><a href=\"#cite_note-Session-8\">&#91;8&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources_(medicine)\" title=\"Wikipedia:Identifying reliable sources (medicine)\"><span title=\"Material near this tag may rely on an unreliable or less reliable medical source. (November 2017)\">unreliable medical source?</span></a></i>&#93;</sup> So recommendations on the use of postmenopausal <a href=\"/wiki/Hormonal_replacement_therapy\" class=\"mw-redirect\" title=\"Hormonal replacement therapy\">hormonal replacement therapy</a> in women with Parkinson's disease or those genetically at risk.<sup id=\"cite_ref-Kompoliti_9-0\" class=\"reference\"><a href=\"#cite_note-Kompoliti-9\">&#91;9&#93;</a></sup> But another group of scientists found a positive association between estrogen use and lower symptom severity in women with early PD not yet taking <a href=\"/wiki/L-dopa\" class=\"mw-redirect\" title=\"L-dopa\">L-dopa</a>.<sup id=\"cite_ref-Pullman_10-0\" class=\"reference\"><a href=\"#cite_note-Pullman-10\">&#91;10&#93;</a></sup>\n</p>\n<h3><span id=\"Estrogen_and_Huntington.27s_disease\"></span><span class=\"mw-headline\" id=\"Estrogen_and_Huntington's_disease\">Estrogen and Huntington's disease</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=8\" title=\"Edit section: Estrogen and Huntington&#039;s disease\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Huntington's disease (HD) is a polyglutamine <a href=\"/wiki/Disease\" title=\"Disease\">disorder</a> based on an expanded CAG triplet repeat<sup id=\"cite_ref-Huntington&#39;s_11-0\" class=\"reference\"><a href=\"#cite_note-Huntington&#39;s-11\">&#91;11&#93;</a></sup>  leading to <a href=\"/wiki/Cerebrum\" title=\"Cerebrum\">cerebral</a> and striatal neurodegeneration.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup> Potential sex differences concerning the age of onset and the course of the disease are poorly defined, as the difficulties of matching female and male HD patients regarding their CAG repeat lengths limit comparability.<sup id=\"cite_ref-Bode_13-0\" class=\"reference\"><a href=\"#cite_note-Bode-13\">&#91;13&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Estrogen_and_Amyotrophic_lateral_sclerosis\">Estrogen and Amyotrophic lateral sclerosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=9\" title=\"Edit section: Estrogen and Amyotrophic lateral sclerosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>ALS occurs more commonly in men than in women, and women get the disease later in life compared to men.<sup id=\"cite_ref-Rudnicki_14-0\" class=\"reference\"><a href=\"#cite_note-Rudnicki-14\">&#91;14&#93;</a></sup> \nThis suggested the possible protective role of estrogen in ALS. By conducting treatment of 17\u03b2-estradiol to <a href=\"/wiki/Ovariectomy\" class=\"mw-redirect\" title=\"Ovariectomy\">ovariectomy</a> treated mice, scientists found significantly delay of disease progression.<sup id=\"cite_ref-Groenerveld_15-0\" class=\"reference\"><a href=\"#cite_note-Groenerveld-15\">&#91;15&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Estrogen_Replacement_Therapy\">Estrogen Replacement Therapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=10\" title=\"Edit section: Estrogen Replacement Therapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Hormone_Replacement_Therapy\" class=\"mw-redirect\" title=\"Hormone Replacement Therapy\">Hormone Replacement Therapy</a></div>\n<p><a href=\"/wiki/Estrogen_Replacement_Therapy\" class=\"mw-redirect\" title=\"Estrogen Replacement Therapy\">Estrogen Replacement Therapy</a> (HRT) is a kind of <a href=\"/wiki/Hormone_replacement_therapy\" title=\"Hormone replacement therapy\">hormone replacement therapy</a>.\nIts goal is to mitigate discomfort caused by diminished circulating estrogen after menopause.\nThe 2002 <a href=\"/wiki/Women%27s_Health_Initiative\" title=\"Women&#39;s Health Initiative\">Women's Health Initiative</a> of the <a href=\"/wiki/National_Institutes_of_Health\" title=\"National Institutes of Health\">National Institutes of Health</a> found disparate results for all cause mortality with hormone replacement, finding it to be lower when HRT was begun earlier, between age 50-59, but higher when begun after age 60. In older patients, there was an increased incidence of <a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">breast cancer</a>, <a href=\"/wiki/Heart_attack\" class=\"mw-redirect\" title=\"Heart attack\">heart attacks</a> and <a href=\"/wiki/Stroke\" title=\"Stroke\">stroke</a>, although a reduced incidence of colorectal cancer and bone fracture.<sup id=\"cite_ref-JAMA_16-0\" class=\"reference\"><a href=\"#cite_note-JAMA-16\">&#91;16&#93;</a></sup> Some of the WHI findings were again found in a larger national study done in the UK, known as <a href=\"/wiki/The_Million_Women_Study\" class=\"mw-redirect\" title=\"The Million Women Study\">The Million Women Study</a>. As a result of these findings, the number of women taking hormone treatment dropped precipitously.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>  The Women's Health Initiative recommended that women with non-surgical menopause take the lowest feasible dose of HRT for the shortest possible time to minimize associated risks.<sup id=\"cite_ref-JAMA_16-1\" class=\"reference\"><a href=\"#cite_note-JAMA-16\">&#91;16&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Main_Pathways\">Main Pathways</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=11\" title=\"Edit section: Main Pathways\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The role of estrogens is mostly mediated by two nuclear receptors (ER alpha and ER beta) and a membrane-associated G-protein (GPR30 or GPER), and it is not limited to reproduction, but it extends to the skeletal, cardiovascular and central nervous systems. Various pathologies such as cancer, inflammatory, neurodegenerative and metabolic diseases are often associated with dysfunctions of the estrogen system. Therapeutic interventions by agents that affect the estrogen signaling pathway might be useful in the treatment of many dissimilar diseases.<sup id=\"cite_ref-Paterni_18-0\" class=\"reference\"><a href=\"#cite_note-Paterni-18\">&#91;18&#93;</a></sup> These pathways also shown great impact on neurodegenerative disease.\n</p>\n<h3><span class=\"mw-headline\" id=\"Application_2\">Application</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=12\" title=\"Edit section: Application\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The receptors of estrogen are specially distributed in different tissues, which have different influence on their downstream genes. The activation of the two different estrogen receptors has different effects on human. ER\u03b1 and ER\u03b2 also mediate <a href=\"/wiki/Selective_estrogen-receptor_modulator\" class=\"mw-redirect\" title=\"Selective estrogen-receptor modulator\">Selective estrogen-receptor modulators</a>' (SERMs') function,<sup id=\"cite_ref-Riggs_19-0\" class=\"reference\"><a href=\"#cite_note-Riggs-19\">&#91;19&#93;</a></sup> but the selective ER\u03b1 agitator can always cause some side effects such as breast cancer or endometrial hyperplasia, while the selective ER\u03b2 agitator may play an active effect on such diseases. So, the selective ER\u03b2 agitator has more clinical value for neurodegenerative diseases). In post-menopausal women, high levels of testosterone and estrogen higher the risk 2-3 times than lower level situation. Women that are not taking hormone replacement therapy (HRT) have lesser risk of breast cancer because of the insulin level increase.<sup id=\"cite_ref-Tariq_20-0\" class=\"reference\"><a href=\"#cite_note-Tariq-20\">&#91;20&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Nonsteroidal_estrogens_and_neurodegenerative_diseases\">Nonsteroidal estrogens and neurodegenerative diseases</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=13\" title=\"Edit section: Nonsteroidal estrogens and neurodegenerative diseases\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Nonsteroidal estrogens include <a href=\"/wiki/Xenoestrogens\" class=\"mw-redirect\" title=\"Xenoestrogens\">xenoestrogens</a>, <a href=\"/wiki/Phytoestrogens\" class=\"mw-redirect\" title=\"Phytoestrogens\">phytoestrogens</a> and <a href=\"/wiki/Mycoestrogens\" class=\"mw-redirect\" title=\"Mycoestrogens\">mycoestrogens</a>. They are very useful in neurodegenerative diseases' therapy when considering about the side effects caused by estradiol. \nAs the development of chemical synthesis, it becomes possible for people to construct new molecules. Drug companies can exploit naturally existing compounds and synthetic compounds that have estrogen-like activity to produce patented proprietary drugs, especially the <a href=\"/wiki/Contraceptives\" class=\"mw-redirect\" title=\"Contraceptives\">contraceptives</a>.<sup id=\"cite_ref-Natural_Estrogens_21-0\" class=\"reference\"><a href=\"#cite_note-Natural_Estrogens-21\">&#91;21&#93;</a></sup> \n<a href=\"/wiki/Phytoestrogens\" class=\"mw-redirect\" title=\"Phytoestrogens\">Phytoestrogens</a> are plant derived estrogens and have similar structures with <a href=\"/wiki/17beta-estradiol\" class=\"mw-redirect\" title=\"17beta-estradiol\">17beta-estradiol</a> thus may cause estrogenic or anti-estrogenic effects.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Application_3\">Application</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=14\" title=\"Edit section: Application\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Nonsteroidal estrogens prevalently exist in our environment and have both positive and negative effects on our daily life. But as a possible way to get access to neurodegenerative disease treatment, scientists have developed multiple ways to screen these estrogens and select the ones that have less side effects.\nBipartite recombinant yeast system and dual fluorescence report system are designed to screen these potential chemicals.<sup id=\"cite_ref-Liang_23-0\" class=\"reference\"><a href=\"#cite_note-Liang-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-Zhang_24-0\" class=\"reference\"><a href=\"#cite_note-Zhang-24\">&#91;24&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Estrogen_and_neurodegenerative_diseases&amp;action=edit&amp;section=15\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-Fratiglioni-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Fratiglioni_1-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fratiglioni, L; Grut M; Forsell Y;  et al. (December 1991). \"Prevalence of Alzheimer's disease and other dementias in an elderly urban population\". <i>Neurology</i>. <b>41</b> (12): 1886\u20131886. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1212/wnl.41.12.1886\">10.1212/wnl.41.12.1886</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Prevalence+of+Alzheimer%27s+disease+and+other+dementias+in+an+elderly+urban+population&amp;rft.volume=41&amp;rft.issue=12&amp;rft.pages=1886-1886&amp;rft.date=1991-12&amp;rft_id=info%3Adoi%2F10.1212%2Fwnl.41.12.1886&amp;rft.aulast=Fratiglioni&amp;rft.aufirst=L&amp;rft.au=Grut+M&amp;rft.au=Forsell+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Leung-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Leung_2-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Leung, Kin-Chuen; Gudmundur Johannsson; Gary M. Leong; Ken K. Y. Ho (October 2004). \"Estrogen Regulation of Growth Hormone Action\". <i>Endocrine Reviews</i>. <b>25</b>: 693\u2013721. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1210/er.2003-0035\">10.1210/er.2003-0035</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Endocrine+Reviews&amp;rft.atitle=Estrogen+Regulation+of+Growth+Hormone+Action&amp;rft.volume=25&amp;rft.pages=693-721&amp;rft.date=2004-10&amp;rft_id=info%3Adoi%2F10.1210%2Fer.2003-0035&amp;rft.aulast=Leung&amp;rft.aufirst=Kin-Chuen&amp;rft.au=Gudmundur+Johannsson&amp;rft.au=Gary+M.+Leong&amp;rft.au=Ken+K.+Y.+Ho&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Pettersson-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Pettersson_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pettersson, Katarina; Jan-\u00c5ke Gustafsson (March 2001). \"Role of Estrogen Receptor Beta in Estrogen Action\". <i>Annual Review of Physiology</i>. <b>63</b>: 165\u2013192. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1146/annurev.physiol.63.1.165\">10.1146/annurev.physiol.63.1.165</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11181953\">11181953</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annual+Review+of+Physiology&amp;rft.atitle=Role+of+Estrogen+Receptor+Beta+in+Estrogen+Action&amp;rft.volume=63&amp;rft.pages=165-192&amp;rft.date=2001-03&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev.physiol.63.1.165&amp;rft_id=info%3Apmid%2F11181953&amp;rft.aulast=Pettersson&amp;rft.aufirst=Katarina&amp;rft.au=Jan-%C3%85ke+Gustafsson&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sharma-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sharma_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sharma_4-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sharma, Hari S.; Muresanu, Dafin F.; Sharma, Aruna (October 2013). \"Novel therapeutic strategies using nanodrug delivery, stem cells and combination therapy for CNS trauma and neurodegenerative disorders\". <i>EXPERT REVIEW OF NEUROTHERAPEUTICS</i>. <b>13</b> (10): 1085\u20131088. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1586/14737175.2013.836297\">10.1586/14737175.2013.836297</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=EXPERT+REVIEW+OF+NEUROTHERAPEUTICS&amp;rft.atitle=Novel+therapeutic+strategies+using+nanodrug+delivery%2C+stem+cells+and+combination+therapy+for+CNS+trauma+and+neurodegenerative+disorders&amp;rft.volume=13&amp;rft.issue=10&amp;rft.pages=1085-1088&amp;rft.date=2013-10&amp;rft_id=info%3Adoi%2F10.1586%2F14737175.2013.836297&amp;rft.aulast=Sharma&amp;rft.aufirst=Hari+S.&amp;rft.au=Muresanu%2C+Dafin+F.&amp;rft.au=Sharma%2C+Aruna&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Gandy-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Gandy_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Gandy_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gandy, S. (July 2003). \"Estrogen and neurodegeneration\". <i>Neurochemistry Research</i>. <b>28</b> (7): 1003\u20138.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurochemistry+Research&amp;rft.atitle=Estrogen+and+neurodegeneration.&amp;rft.volume=28&amp;rft.issue=7&amp;rft.pages=1003-8&amp;rft.date=2003-07&amp;rft.aulast=Gandy&amp;rft.aufirst=S.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Zhang,_She-Qing-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Zhang,_She-Qing_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zhang, She-Qing; et.al (August 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3744472\">\"Octyl Gallate Markedly Promotes Anti-amyloidogenic Processing of APP through Estrogen Receptor-Mediated ADAM10 Activation\"</a>. <i>PLOS ONE</i>. <b>8</b> (8): e71913. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1371/journal.pone.0071913\">10.1371/journal.pone.0071913</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3744472\">3744472</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23977176\">23977176</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=Octyl+Gallate+Markedly+Promotes+Anti-amyloidogenic+Processing+of+APP+through+Estrogen+Receptor-Mediated+ADAM10+Activation&amp;rft.volume=8&amp;rft.issue=8&amp;rft.pages=e71913&amp;rft.date=2013-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3744472&amp;rft_id=info%3Apmid%2F23977176&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0071913&amp;rft.aulast=Zhang&amp;rft.aufirst=She-Qing&amp;rft.au=et.al&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3744472&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-JAFFE-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-JAFFE_7-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">JAFFE, AB; et.al (1994). \"ESTROGEN REGULATES METABOLISM OF ALZHEIMER AMYLOID-BETA PRECURSOR PROTEIN\". <i>Journal of Biological Chemistry</i>. <b>269</b> (18): 13065\u201313068. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8175728\">8175728</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Biological+Chemistry&amp;rft.atitle=ESTROGEN+REGULATES+METABOLISM+OF+ALZHEIMER+AMYLOID-BETA+PRECURSOR+PROTEIN&amp;rft.volume=269&amp;rft.issue=18&amp;rft.pages=13065-13068&amp;rft.date=1994&amp;rft_id=info%3Apmid%2F8175728&amp;rft.aulast=JAFFE&amp;rft.aufirst=AB&amp;rft.au=et.al&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Session-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Session_8-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Session, D.R.;  et al. (April 1994). \"Estrogens and Parkinson's disease\". <i><a href=\"/wiki/Medical_Hypotheses\" title=\"Medical Hypotheses\">Medical Hypotheses</a></i>. <b>42</b> (4): 280\u2013282. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/0306-9877%2894%2990133-3\">10.1016/0306-9877(94)90133-3</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medical+Hypotheses&amp;rft.atitle=Estrogens+and+Parkinson%27s+disease&amp;rft.volume=42&amp;rft.issue=4&amp;rft.pages=280-282&amp;rft.date=1994-04&amp;rft_id=info%3Adoi%2F10.1016%2F0306-9877%2894%2990133-3&amp;rft.aulast=Session&amp;rft.aufirst=D.R.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Kompoliti-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Kompoliti_9-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kompoliti, K (May 2003). \"Estrogen and Parkinson's disease\". <i>Frontiers in Bioscience</i>. <b>8</b>: 391\u2013400. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2741/1070\">10.2741/1070</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Bioscience&amp;rft.atitle=Estrogen+and+Parkinson%27s+disease&amp;rft.volume=8&amp;rft.pages=391-400&amp;rft.date=2003-05&amp;rft_id=info%3Adoi%2F10.2741%2F1070&amp;rft.aulast=Kompoliti&amp;rft.aufirst=K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Pullman-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Pullman_10-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pullman, R. Saunders;  et al. (April 1999). \"The effect of estrogen replacement on early Parkinson's disease\". <i>Neurology</i>. <b>52</b>: 1417. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1212/wnl.52.7.1417\">10.1212/wnl.52.7.1417</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=The+effect+of+estrogen+replacement+on+early+Parkinson%27s+disease&amp;rft.volume=52&amp;rft.pages=1417&amp;rft.date=1999-04&amp;rft_id=info%3Adoi%2F10.1212%2Fwnl.52.7.1417&amp;rft.aulast=Pullman&amp;rft.aufirst=R.+Saunders&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Huntington&#39;s-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Huntington&#39;s_11-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">The Huntington's Disease Collaborative Research Group (1993). \"The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes\". <i>Cell</i>. <b>72</b>: 971\u2013983. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/0092-8674%2893%2990585-e\">10.1016/0092-8674(93)90585-e</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8458085\">8458085</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=The+Huntington%27s+Disease+Collaborative+Research+Group.+A+novel+gene+containing+a+trinucleotide+repeat+that+is+expanded+and+unstable+on+Huntington%27s+disease+chromosomes.&amp;rft.volume=72&amp;rft.pages=971-983&amp;rft.date=1993&amp;rft_id=info%3Adoi%2F10.1016%2F0092-8674%2893%2990585-e&amp;rft_id=info%3Apmid%2F8458085&amp;rft.au=The+Huntington%27s+Disease+Collaborative+Research+Group&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vonsattel, J.P.;  et al. (198). \"Huntington disease\". <i>Neuropathol. Exp. Neurol</i>. <b>57</b>: 369\u2013384. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/00005072-199805000-00001\">10.1097/00005072-199805000-00001</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropathol.+Exp.+Neurol&amp;rft.atitle=Huntington+disease&amp;rft.volume=57&amp;rft.pages=369-384&amp;rft.date=198&amp;rft_id=info%3Adoi%2F10.1097%2F00005072-199805000-00001&amp;rft.aulast=Vonsattel&amp;rft.aufirst=J.P.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Bode-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bode_13-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bode, Felix J.;  et al. (May 2008). \"Sex differences in a transgenic rat model of Huntington's disease: decreased 17\u03b2-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males\". <i>Human Molecular Genetics</i>. <b>17</b> (17): 2595\u20132609. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/hmg/ddn159\">10.1093/hmg/ddn159</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Molecular+Genetics&amp;rft.atitle=Sex+differences+in+a+transgenic+rat+model+of+Huntington%27s+disease%3A+decreased+17%CE%B2-estradiol+levels+correlate+with+reduced+numbers+of+DARPP32%2B+neurons+in+males&amp;rft.volume=17&amp;rft.issue=17&amp;rft.pages=2595-2609&amp;rft.date=2008-05&amp;rft_id=info%3Adoi%2F10.1093%2Fhmg%2Fddn159&amp;rft.aulast=Bode&amp;rft.aufirst=Felix+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Rudnicki-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Rudnicki_14-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rudnicki, SA (October 1999). \"Estrogen and Amyotrophic lateral sclerosis\". <i>Journal of the Neurological Sciences</i>. <b>169</b>: 126\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/s0022-510x%2899%2900234-8\">10.1016/s0022-510x(99)00234-8</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Neurological+Sciences&amp;rft.atitle=Estrogen+and+Amyotrophic+lateral+sclerosis&amp;rft.volume=169&amp;rft.pages=126-7&amp;rft.date=1999-10&amp;rft_id=info%3Adoi%2F10.1016%2Fs0022-510x%2899%2900234-8&amp;rft.aulast=Rudnicki&amp;rft.aufirst=SA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Groenerveld-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Groenerveld_15-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Groenerveld, G.J.;  et al. (September 2004). \"Ovariectomy and 17\u03b2-estradiol modulate disease progression of a mouse model of ALS\". <i>Brain Research</i>. <b>1021</b> (1): 128\u2013131. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.brainres.2004.06.024\">10.1016/j.brainres.2004.06.024</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain+Research&amp;rft.atitle=Ovariectomy+and+17%CE%B2-estradiol+modulate+disease+progression+of+a+mouse+model+of+ALS&amp;rft.volume=1021&amp;rft.issue=1&amp;rft.pages=128-131&amp;rft.date=2004-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.brainres.2004.06.024&amp;rft.aulast=Groenerveld&amp;rft.aufirst=G.J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-JAMA-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-JAMA_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-JAMA_16-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Writing Group for the Women's Health Initiative Investigators (2002). <a rel=\"nofollow\" class=\"external text\" href=\"http://jama.ama-assn.org/cgi/content/abstract/288/3/321\">\"Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial\"</a>. <i><a href=\"/wiki/Journal_of_the_American_Medical_Association\" class=\"mw-redirect\" title=\"Journal of the American Medical Association\">JAMA</a></i>. <b>288</b> (3): 321\u2013333. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.288.3.321\">10.1001/jama.288.3.321</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12117397\">12117397</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Risks+and+Benefits+of+Estrogen+Plus+Progestin+in+Healthy+Postmenopausal+Women%3A+Principal+Results+From+the+Women%27s+Health+Initiative+Randomized+Controlled+Trial&amp;rft.volume=288&amp;rft.issue=3&amp;rft.pages=321-333&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.288.3.321&amp;rft_id=info%3Apmid%2F12117397&amp;rft.au=Writing+Group+for+the+Women%27s+Health+Initiative+Investigators&amp;rft_id=http%3A%2F%2Fjama.ama-assn.org%2Fcgi%2Fcontent%2Fabstract%2F288%2F3%2F321&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chlebowski, RT; Kuller LH; Prentice RL; Stefanick ML; Manson JE; Gass M;  et al. (2009). <a rel=\"nofollow\" class=\"external text\" href=\"http://content.nejm.org/cgi/content/full/360/6/573\">\"Breast cancer after use of estrogen plus progestin in postmenopausal women\"</a>. <i><a href=\"/wiki/New_England_Journal_of_Medicine\" class=\"mw-redirect\" title=\"New England Journal of Medicine\">NEJM</a></i>. <b>360</b> (6): 573\u201387. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa0807684\">10.1056/NEJMoa0807684</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3963492\">3963492</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19196674\">19196674</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NEJM&amp;rft.atitle=Breast+cancer+after+use+of+estrogen+plus+progestin+in+postmenopausal+women&amp;rft.volume=360&amp;rft.issue=6&amp;rft.pages=573-87&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3963492&amp;rft_id=info%3Apmid%2F19196674&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa0807684&amp;rft.aulast=Chlebowski&amp;rft.aufirst=RT&amp;rft.au=Kuller+LH&amp;rft.au=Prentice+RL&amp;rft.au=Stefanick+ML&amp;rft.au=Manson+JE&amp;rft.au=Gass+M&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Ffull%2F360%2F6%2F573&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Paterni-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Paterni_18-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Paterni, Ilaria; Bertini, Simone;  et al. (October 2013). \"Estrogen receptor ligands: a patent review update\". <i>EXPERT OPINION ON THERAPEUTIC PATENTS</i>. <b>23</b> (10): 1247\u20131271. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1517/13543776.2013.805206\">10.1517/13543776.2013.805206</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=EXPERT+OPINION+ON+THERAPEUTIC+PATENTS&amp;rft.atitle=Estrogen+receptor+ligands%3A+a+patent+review+update&amp;rft.volume=23&amp;rft.issue=10&amp;rft.pages=1247-1271&amp;rft.date=2013-10&amp;rft_id=info%3Adoi%2F10.1517%2F13543776.2013.805206&amp;rft.aulast=Paterni&amp;rft.aufirst=Ilaria&amp;rft.au=Bertini%2C+Simone&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Riggs-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Riggs_19-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Riggs, B. Lawrence; Lynn C. Hartmann (February 2003). \"Selective Estrogen-Receptor Modulators \u2014 Mechanisms of Action and Application to Clinical Practice\". <i>New England Journal of Medicine</i>. <b>348</b>: 618\u2013629. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/nejmra022219\">10.1056/nejmra022219</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12584371\">12584371</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=Selective+Estrogen-Receptor+Modulators+%E2%80%94+Mechanisms+of+Action+and+Application+to+Clinical+Practice&amp;rft.volume=348&amp;rft.pages=618-629&amp;rft.date=2003-02&amp;rft_id=info%3Adoi%2F10.1056%2Fnejmra022219&amp;rft_id=info%3Apmid%2F12584371&amp;rft.aulast=Riggs&amp;rft.aufirst=B.+Lawrence&amp;rft.au=Lynn+C.+Hartmann&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Tariq-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Tariq_20-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tariq, Rabia; Sadia Huma; Mariam Zaka Butt; Fatima Amin (August 2013). \"Risk factors and prevalence of breast cancer- a review\". <i>Journal of Pakistan Medical Association</i>. <b>63</b> (8): 1075\u20131078.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Pakistan+Medical+Association&amp;rft.atitle=Risk+factors+and+prevalence+of+breast+cancer-+a+review&amp;rft.volume=63&amp;rft.issue=8&amp;rft.pages=1075-1078&amp;rft.date=2013-08&amp;rft.aulast=Tariq&amp;rft.aufirst=Rabia&amp;rft.au=Sadia+Huma&amp;rft.au=Mariam+Zaka+Butt&amp;rft.au=Fatima+Amin&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Natural_Estrogens-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Natural_Estrogens_21-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://raypeat.com/articles/articles/natural-estrogens.shtml\">\"Natural Estrogens\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Natural+Estrogens&amp;rft_id=http%3A%2F%2Fraypeat.com%2Farticles%2Farticles%2Fnatural-estrogens.shtml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><a href=\"/wiki/Phytoestrogen\" title=\"Phytoestrogen\">Phytoestrogen</a></span>\n</li>\n<li id=\"cite_note-Liang-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Liang_23-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Liang, K; Yang L; Xiao Z; Huang J (January 2009). \"A bipartite recombinant yeast system for the identification of subtype-selective estrogen receptor ligands\". <i>Molecular Biotechnology</i>. <b>41</b> (1): 53\u201362. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s12033-008-9097-9\">10.1007/s12033-008-9097-9</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+Biotechnology&amp;rft.atitle=A+bipartite+recombinant+yeast+system+for+the+identification+of+subtype-selective+estrogen+receptor+ligands&amp;rft.volume=41&amp;rft.issue=1&amp;rft.pages=53-62&amp;rft.date=2009-01&amp;rft_id=info%3Adoi%2F10.1007%2Fs12033-008-9097-9&amp;rft.aulast=Liang&amp;rft.aufirst=K&amp;rft.au=Yang+L&amp;rft.au=Xiao+Z&amp;rft.au=Huang+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Zhang-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Zhang_24-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zhang, X; Zuo Z;  et al. (July 2013). \"Design, synthesis and biological evaluation of novel estrogen-derived steroid metal complexes\". <i>Bioorganic &amp; Medicinal Chemistry Letters</i>. <b>23</b> (13): 3793\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bmcl.2013.04.088\">10.1016/j.bmcl.2013.04.088</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bioorganic+%26+Medicinal+Chemistry+Letters&amp;rft.atitle=Design%2C+synthesis+and+biological+evaluation+of+novel+estrogen-derived+steroid+metal+complexes.&amp;rft.volume=23&amp;rft.issue=13&amp;rft.pages=3793-7&amp;rft.date=2013-07&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bmcl.2013.04.088&amp;rft.aulast=Zhang&amp;rft.aufirst=X&amp;rft.au=Zuo+Z&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEstrogen+and+neurodegenerative+diseases\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n\n<!-- \nNewPP limit report\nParsed by mw2217\nCached time: 20180913223404\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.272 seconds\nReal time usage: 0.306 seconds\nPreprocessor visited node count: 1186/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 44283/2097152 bytes\nTemplate argument size: 592/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 30653/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.136/10.000 seconds\nLua memory usage: 4.21 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  230.472      1 -total\n 55.84%  128.699     22 Template:Cite_journal\n 18.05%   41.594      1 Template:Ums\n 15.57%   35.895      1 Template:Fix\n 10.13%   23.336      3 Template:Main\n  9.17%   21.141      1 Template:Category_handler\n  4.64%   10.691      1 Template:Delink\n  2.64%    6.095      1 Template:Cite_web\n  1.51%    3.479      1 Template:Fix/category\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:41120978-0!canonical and timestamp 20180913223403 and revision id 859417047\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"All_articles_lacking_reliable_references"},{"sortkey":"","hidden":"","*":"Articles_lacking_reliable_references_from_November_2017"},{"sortkey":"","*":"Estrogens"},{"sortkey":"","*":"Neurodegenerative_disorders"},{"sortkey":"","*":"Human_female_endocrine_system"}],"links":[{"ns":14,"exists":"","*":"Category:Articles lacking reliable references from November 2017"},{"ns":0,"exists":"","*":"17beta-estradiol"},{"ns":0,"exists":"","*":"Alzheimer's disease"},{"ns":0,"exists":"","*":"Amyloid plaques"},{"ns":0,"exists":"","*":"Amyloid precursor protein"},{"ns":0,"exists":"","*":"Amyotrophic lateral sclerosis"},{"ns":0,"exists":"","*":"Breast cancer"},{"ns":0,"exists":"","*":"Central nervous system"},{"ns":0,"exists":"","*":"Cerebrum"},{"ns":0,"exists":"","*":"Cholinergic"},{"ns":0,"exists":"","*":"Cognitive"},{"ns":0,"exists":"","*":"Cognitive disorders"},{"ns":0,"exists":"","*":"Contraceptives"},{"ns":0,"exists":"","*":"Coronary heart disease"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Disease"},{"ns":0,"exists":"","*":"Dopamine"},{"ns":0,"exists":"","*":"Estradiol"},{"ns":0,"exists":"","*":"Estriol"},{"ns":0,"exists":"","*":"Estrogen"},{"ns":0,"exists":"","*":"Estrogen Replacement Therapy"},{"ns":0,"exists":"","*":"Estrone"},{"ns":0,"exists":"","*":"Estrous"},{"ns":0,"exists":"","*":"Heart attack"},{"ns":0,"exists":"","*":"Homeostasis"},{"ns":0,"exists":"","*":"Hormonal replacement therapy"},{"ns":0,"exists":"","*":"Hormone"},{"ns":0,"exists":"","*":"Hormone Replacement Therapy"},{"ns":0,"exists":"","*":"Hormone replacement therapy"},{"ns":0,"exists":"","*":"Huntington's disease"},{"ns":0,"exists":"","*":"Journal of the American Medical Association"},{"ns":0,"exists":"","*":"L-dopa"},{"ns":0,"exists":"","*":"Medical Hypotheses"},{"ns":0,"exists":"","*":"Menopause"},{"ns":0,"exists":"","*":"Menstrual"},{"ns":0,"exists":"","*":"Mutation"},{"ns":0,"exists":"","*":"Mycoestrogens"},{"ns":0,"exists":"","*":"National Institutes of Health"},{"ns":0,"exists":"","*":"Neurodegeneration"},{"ns":0,"exists":"","*":"Neurofibrillary tangles"},{"ns":0,"exists":"","*":"Neuroprotectant"},{"ns":0,"exists":"","*":"Neuroprotection"},{"ns":0,"exists":"","*":"Neuroregeneration"},{"ns":0,"exists":"","*":"New England Journal of Medicine"},{"ns":0,"exists":"","*":"Osteoporosis"},{"ns":0,"exists":"","*":"Ovariectomy"},{"ns":0,"exists":"","*":"Oxidative stress"},{"ns":0,"exists":"","*":"Parkinson's disease"},{"ns":0,"exists":"","*":"Phytoestrogen"},{"ns":0,"exists":"","*":"Phytoestrogens"},{"ns":0,"exists":"","*":"Postmenopausal"},{"ns":0,"exists":"","*":"Programmed cell death"},{"ns":0,"exists":"","*":"Protein misfolding"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Selective estrogen-receptor modulator"},{"ns":0,"exists":"","*":"Stroke"},{"ns":0,"exists":"","*":"The Million Women Study"},{"ns":0,"exists":"","*":"Women's Health Initiative"},{"ns":0,"exists":"","*":"Xenoestrogens"},{"ns":0,"*":"Global College of Neuroproetction and Neuroregeneration Annual Conference"},{"ns":0,"*":"Neurorestoration"},{"ns":0,"*":"Nanodrug"},{"ns":4,"exists":"","*":"Wikipedia:Identifying reliable sources (medicine)"}],"templates":[{"ns":10,"exists":"","*":"Template:Main"},{"ns":10,"exists":"","*":"Template:Ums"},{"ns":10,"exists":"","*":"Template:Unreliable medical source"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":828,"exists":"","*":"Module:Main"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"}],"images":["Lock-green.svg","17-alpha-_vs_17-beta-estradiol.svg","Parasagittal_MRI_of_human_head_in_patient_with_benign_familial_macrocephaly_prior_to_brain_injury_(ANIMATED).gif","APP_cleavage_produce_toxic_Abeta.png"],"externallinks":["//doi.org/10.1212/wnl.41.12.1886","//doi.org/10.1210/er.2003-0035","//doi.org/10.1146/annurev.physiol.63.1.165","//www.ncbi.nlm.nih.gov/pubmed/11181953","//doi.org/10.1586/14737175.2013.836297","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3744472","//doi.org/10.1371/journal.pone.0071913","//www.ncbi.nlm.nih.gov/pubmed/23977176","//www.ncbi.nlm.nih.gov/pubmed/8175728","//doi.org/10.1016/0306-9877(94)90133-3","//doi.org/10.2741/1070","//doi.org/10.1212/wnl.52.7.1417","//doi.org/10.1016/0092-8674(93)90585-e","//www.ncbi.nlm.nih.gov/pubmed/8458085","//doi.org/10.1097/00005072-199805000-00001","//doi.org/10.1093/hmg/ddn159","//doi.org/10.1016/s0022-510x(99)00234-8","//doi.org/10.1016/j.brainres.2004.06.024","http://jama.ama-assn.org/cgi/content/abstract/288/3/321","//doi.org/10.1001/jama.288.3.321","//www.ncbi.nlm.nih.gov/pubmed/12117397","http://content.nejm.org/cgi/content/full/360/6/573","//doi.org/10.1056/NEJMoa0807684","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3963492","//www.ncbi.nlm.nih.gov/pubmed/19196674","//doi.org/10.1517/13543776.2013.805206","//doi.org/10.1056/nejmra022219","//www.ncbi.nlm.nih.gov/pubmed/12584371","http://raypeat.com/articles/articles/natural-estrogens.shtml","//doi.org/10.1007/s12033-008-9097-9","//doi.org/10.1016/j.bmcl.2013.04.088"],"sections":[{"toclevel":1,"level":"2","line":"Estrogen","number":"1","index":"1","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":1430,"anchor":"Estrogen"},{"toclevel":2,"level":"3","line":"Application","number":"1.1","index":"2","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":3244,"anchor":"Application"},{"toclevel":1,"level":"2","line":"Neurodegenerative Diseases","number":"2","index":"3","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":3744,"anchor":"Neurodegenerative_Diseases"},{"toclevel":2,"level":"3","line":"Efforts Made on Therapy","number":"2.1","index":"4","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":4610,"anchor":"Efforts_Made_on_Therapy"},{"toclevel":1,"level":"2","line":"Estrogen and neurodegenerative diseases","number":"3","index":"5","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":5976,"anchor":"Estrogen_and_neurodegenerative_diseases"},{"toclevel":2,"level":"3","line":"Estrogen and Alzheimer's disease","number":"3.1","index":"6","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":7228,"anchor":"Estrogen_and_Alzheimer's_disease"},{"toclevel":2,"level":"3","line":"Estrogen and Parkinson's disease","number":"3.2","index":"7","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":8643,"anchor":"Estrogen_and_Parkinson's_disease"},{"toclevel":2,"level":"3","line":"Estrogen and Huntington's disease","number":"3.3","index":"8","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":9925,"anchor":"Estrogen_and_Huntington's_disease"},{"toclevel":2,"level":"3","line":"Estrogen and Amyotrophic lateral sclerosis","number":"3.4","index":"9","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":11287,"anchor":"Estrogen_and_Amyotrophic_lateral_sclerosis"},{"toclevel":1,"level":"2","line":"Estrogen Replacement Therapy","number":"4","index":"10","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":12169,"anchor":"Estrogen_Replacement_Therapy"},{"toclevel":2,"level":"3","line":"Main Pathways","number":"4.1","index":"11","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":14291,"anchor":"Main_Pathways"},{"toclevel":2,"level":"3","line":"Application","number":"4.2","index":"12","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":15234,"anchor":"Application_2"},{"toclevel":1,"level":"2","line":"Nonsteroidal estrogens and neurodegenerative diseases","number":"5","index":"13","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":16705,"anchor":"Nonsteroidal_estrogens_and_neurodegenerative_diseases"},{"toclevel":2,"level":"3","line":"Application","number":"5.1","index":"14","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":17588,"anchor":"Application_3"},{"toclevel":1,"level":"2","line":"References","number":"6","index":"15","fromtitle":"Estrogen_and_neurodegenerative_diseases","byteoffset":18694,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Estrogen and neurodegenerative diseases","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q17001872"}]}}